146 related articles for article (PubMed ID: 36707945)
21. Prognostic value of the preoperative and early trends in postoperative serum thyroglobulin antibody levels among patients with papillary thyroid carcinoma and concomitant Hashimoto's thyroiditis.
Xu S; Huang H; Qian J; Wang X; Xu Z; Liu S; Liu J
Endocrine; 2023 May; 80(2):392-398. PubMed ID: 36534327
[TBL] [Abstract][Full Text] [Related]
22. The value of preoperative antithyroidperoxidase antibody as a novel predictor of recurrence in papillary thyroid carcinoma.
Song E; Oh HS; Jeon MJ; Chung KW; Hong SJ; Ryu JS; Baek JH; Lee JH; Kim WG; Kim WB; Shong YK; Kim TY
Int J Cancer; 2019 Mar; 144(6):1414-1420. PubMed ID: 30357831
[TBL] [Abstract][Full Text] [Related]
23. Impact factors for the outcome of the first
Shangguan L; Fang S; Zhang P; Han S; Shen X; Geng Y; Luo D; Zhao C
Ann Nucl Med; 2019 Mar; 33(3):177-183. PubMed ID: 30515649
[TBL] [Abstract][Full Text] [Related]
24. Lymph node fine-needle aspiration washout thyroglobulin in papillary thyroid cancer: Diagnostic value and the effect of thyroglobulin antibodies.
Konca Degertekin C; Yalcin MM; Cerit T; Ozkan C; Kalan I; Iyidir OT; Altinova AE; Akturk M; Toruner F; Akin M; Cakir N
Endocr Res; 2016 Nov; 41(4):281-289. PubMed ID: 26905960
[TBL] [Abstract][Full Text] [Related]
25. Time trends of thyroglobulin antibody in ablated papillary thyroid carcinoma patients: Can we predict the rate of negative conversion?
Song E; Ahn J; Oh HS; Jeon MJ; Kim WG; Kim WB; Shong YK; Baek JH; Lee JH; Ryu JS; Chung KW; Hong SJ; Kim TY
Oral Oncol; 2019 Apr; 91():29-34. PubMed ID: 30926059
[TBL] [Abstract][Full Text] [Related]
26. Pre-Operative Antithyroid Antibodies in Differentiated Thyroid Cancer.
Noel JE; Thatipamala P; Hung KS; Chen J; Shi RZ; Orloff LA
Endocr Pract; 2021 Nov; 27(11):1114-1118. PubMed ID: 34217894
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of changes in serum thyroglobulin antibody levels of pre- and post-total thyroidectomy in thyroglobulin antibody-positive papillary thyroid carcinoma patients.
Tsushima Y; Miyauchi A; Ito Y; Kudo T; Masuoka H; Yabuta T; Fukushima M; Kihara M; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Kikumori T; Imai T; Kiuchi T
Endocr J; 2013; 60(7):871-6. PubMed ID: 23585494
[TBL] [Abstract][Full Text] [Related]
28. The relationship between BRAFV600E, NF-κB and TgAb expression in papillary thyroid carcinoma.
Li W; Ming H; Sun D; Li W; Wang D; Zhang G; Tan J
Pathol Res Pract; 2017 Mar; 213(3):183-188. PubMed ID: 28214213
[TBL] [Abstract][Full Text] [Related]
29. Correlation between thyroid autoantibodies and the risk of thyroid papillary carcinoma.
Peng X; Zhu X; Cheng F; Zhou B; Zhu X; Zhu L
Gland Surg; 2020 Aug; 9(4):950-955. PubMed ID: 32953604
[TBL] [Abstract][Full Text] [Related]
30. Thyroglobulin Antibody (TgAb) Positive is an Independent Risk Factor for Lymph Node Metastasis in Patients with Differentiated Thyroid Carcinoma.
Lai Y; Gu Y; Yu M; Deng J
Int J Gen Med; 2023; 16():5979-5988. PubMed ID: 38144437
[TBL] [Abstract][Full Text] [Related]
31. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.
Vasileiadis I; Boutzios G; Charitoudis G; Koukoulioti E; Karatzas T
Ann Surg Oncol; 2014 Aug; 21(8):2725-32. PubMed ID: 24595799
[TBL] [Abstract][Full Text] [Related]
32. Effect of Lymph Node Metastasis on Change of Positive Thyroglobulin Antibody in Differentiated Thyroid Carcinoma after Initial Treatment.
Zhang T; Song LP; Zhao T; Gao W; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):539-543. PubMed ID: 28877833
[TBL] [Abstract][Full Text] [Related]
33. Preoperatively Predicting the Central Lymph Node Metastasis for Papillary Thyroid Cancer Patients With Hashimoto's Thyroiditis.
Min Y; Huang Y; Wei M; Wei X; Chen H; Wang X; Chen J; Xiang K; Feng Y; Yin G
Front Endocrinol (Lausanne); 2021; 12():713475. PubMed ID: 34367075
[TBL] [Abstract][Full Text] [Related]
34. Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.
Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
J Clin Endocrinol Metab; 2012 Jul; 97(7):2380-7. PubMed ID: 22539585
[TBL] [Abstract][Full Text] [Related]
35. No Association of Preablation Thyroglobulin Antibody Positivity and Outcome in Pediatric Patients With Papillary Thyroid Carcinoma.
Xu Y; Shi L; Wu J; Li H; Wang Y; Liu B
Clin Nucl Med; 2023 Sep; 48(9):763-767. PubMed ID: 37385237
[TBL] [Abstract][Full Text] [Related]
36. Predictive Value of FNA-Tg and TgAb in Cervical Lymph Node Metastasis of Papillary Thyroid Carcinoma.
Wu X; Liu Y; Li K; Yang Y; Lai P; Li J; Kou S
Technol Cancer Res Treat; 2022; 21():15330338221127605. PubMed ID: 36128843
[No Abstract] [Full Text] [Related]
37. Clinical Impact of Detectable Antithyroglobulin Antibodies Below the Reference Limit (Borderline) in Patients with Papillary Thyroid Carcinoma with Undetectable Serum Thyroglobulin and Normal Neck Ultrasonography After Ablation: A Prospective Study.
Côrtes MCS; Rosario PW; Oliveira LFF; Calsolari MR
Thyroid; 2018 Feb; 28(2):229-235. PubMed ID: 29325506
[TBL] [Abstract][Full Text] [Related]
38. Ultrasound, laboratory and histopathological insights in diagnosing papillary thyroid carcinoma in a paediatric population: a single centre follow-up study between 2000-2022.
Januś D; Wójcik M; Taczanowska-Niemczuk A; Kiszka-Wiłkojć A; Kujdowicz M; Czogała M; Górecki W; Starzyk JB
Front Endocrinol (Lausanne); 2023; 14():1170971. PubMed ID: 37274328
[TBL] [Abstract][Full Text] [Related]
39. Prognosis of papillary thyroid cancers with positive serum thyroglobulin antibody after total thyroidectomy.
Kuo SF; Chao TC; Chang HY; Hsueh C; Lin CL; Chiang KC; Chuang WY; Chen YC; Lin JD
Asian J Surg; 2017 May; 40(3):186-192. PubMed ID: 26553529
[TBL] [Abstract][Full Text] [Related]
40. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
